skip to Main Content

November 11, 2020
TAGline November 2020
TAGline
‘The Struggle of a Lifetime’ (Continued): The words of the late Honorable John Lewis ring powerfully true today. In the U.S., as we welcome a new President-elect and Vice President-elect, we must also defend democracy to ensure a complete, peaceful transition of power. We engage in the struggles generations before…

November 9, 2020
Treatment Action Group and AVAC Statement on Pfizer/BioNTech COVID-19 Vaccine Efficacy Announcement
Statement / Press
Treatment Action Group (TAG) and AVAC welcome today’s announcement that preliminary data from the efficacy trial of Pfizer/BioNTech’s mRNA COVID-19 vaccine indicates a high level of protection against COVID-19. Our organizations urge caution, however, given the very limited information that is available only through a company press release.

November 9, 2020
TAG Welcomes the Election of Joseph R. Biden Jr. and Kamala D. Harris
Statement / Press
Treatment Action Group (TAG) congratulates President-elect Joe Biden and Vice President-elect Kamala Harris on their ascension to the highest offices of the United States. Their victory in both the popular and electoral vote is historic.

November 9, 2020
Letter to Special Rapporteur on Cultural Rights
Letter / Comment
Our current letter follows an earlier letter dated June 23, 2020 and calls on the Special Rapporteur for cultural rights to explicitly acknowledge the human rights dimensions of science and reaffirm the right of everyone to participate in and enjoy the benefits of scientific progress and its applications in her…

October 21, 2020
Finally—A New Four-Month Treatment for Drug-Susceptible TB!
Statement / Press
Treatment Action Group (TAG) and the Community Research Advisors Group (CRAG) welcome the news of a safe and effective regimen for shortening tuberculosis (TB) treatment to just four months.

October 1, 2020
Research in Action Awards 2020
Please join us at our annual, and first ever virtual, Research in Action Awards on Thursday, November 19, 2020. At this time of great turmoil and when activism to end infectious disease is more vital than ever, it’s so important to gather virtually to celebrate life, commemorate those we’ve lost,…

September 21, 2020
Advancing Access through Market Interventions: Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down
Publication
This policy brief examines lessons learned from the Xpert MTB/RIF TB test buy-down and provides recommendations and pro-access conditions that should be applied to R&D funding, buy-down, and other market intervention agreements for COVID-19 diagnostics.

September 18, 2020
Public Investment in Bedaquiline Up to Five-Fold That of Johnson & Johnson
Statement / Press
Treatment Action Group’s independent, peer-reviewed analysis found public investment in the development of bedaquiline was up to five times that of Johnson and Johnson. This finding appears in the new PLOS ONE article, “Public Investments in the Clinical Development of Bedaquiline.”

September 16, 2020
Response to HUD’s Proposed Rule Change: Making Admission or Placement Determinations Based on Sex in Facilities Under Community Planning and Development Housing Programs
Letter / Comment
TAG joined numerous other public health and housing organizations in strongly opposing the proposed rule that would allow certain HUD-funded shelters to deny services to transgender people. HUD should withdraw this rule and work to ensure all people have access to shelter and housing, especially during a deadly pandemic.

September 13, 2020
Treatment Action Group Condemns Reported Bullying, Harassment, and Racism at Stop TB Partnership
Statement / Press
Treatment Action Group (TAG) strongly condemns alleged bullying, harassment, and racism directed toward staff and contractors of the Stop TB Partnership, as reported by The New York Times. As a long-term and current grantee of the Stop TB Partnership, we stand in solidarity with current and former staff and contractors…

Back To Top